You need to provide
This test is for
What is CA15.3?
This assay is useful for predicting early recurrence in women treated for Carcinoma Breast. It is specially useful for serial testing in women with prior Stage II / III breast cancer who are clinically free of disease.
MEDCIS Pathlabs India Private Limited has emerged as a Clinical Investigation Services provider of world-class healthcare services at affordable costs, in all medical branches. With increased use of global technology in diagnosis, MEDCIS Pathlabs is committed in helping improve the quality of patient care by providing reports that support clinical decision-making for doctors. MEDCIS has build on strategy to deliver integrated testing solutions to our customers. Rather than competing with its...
Nice work keep going...